Search Results
Aug 14, 2025, 16:01 ET Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify
More news about: Co-Diagnostics
Aug 14, 2025, 13:40 ET Ultima Genomics' ppmSeq™ Delivers Unmatched Combination of Sensitivity and Efficiency for Whole-Genome MRD Detection
down to 0.8 x 10-7 (0.8 parts-per-ten million) for gDNA and cell-free DNA. Superior dsDNA recovery rates and lower sequencing requirements. ppmSeq demonstrated superior double-stranded DNA (dsDNA) recovery rates, reducing sequencing requirements by 10- to 100-fold and
More news about: Ultima Genomics
Aug 14, 2025, 12:22 ET Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment
that affects the airways. The company's DNA medicine platform represents a novel approach to treating HPV-related diseases and cancers, with INO-3107 showing significant clinical benefit by reducing
More news about: USA News Group
Aug 14, 2025, 11:44 ET POP Launches Canine Health Study with Innovative Pet Lab and Embark to Advance Data-Driven Pet Wellness
Veterinary, the global leader in dog DNA testing, will offer breed, trait, and genetic risk profiling to support individualized interpretation. This comprehensive study will investigate how a personalized protocol—combining diet, gut diagnostics, DNA, and behavior data—can inform smarter, more
More news about: POP LABS (Pet Longevity Research Limited)
Aug 14, 2025, 10:00 ET Mopec Group Strategically Consolidates Operations to Michigan Headquarters
right step for the company, its customers, and its future. "In Michigan, our culture of innovation and commitment to excellence is written in our DNA, which is why we're so thrilled to partner with a global leader like Mopec Group to grow their presence and impact in the state," said MEDC CEO
More news about: Mopec
Aug 14, 2025, 08:00 ET PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results
EsoGuard® Esophageal DNA Test revenue for 2Q25 and processed 2,756 EsoGuard tests.MolDX‑participating Medicare Administrative Contractors (MACs) to convene medical
More news about: PAVmed Inc.
Aug 14, 2025, 04:12 ET Vitamin B12 Market Set to Surpass USD 444.47 Million by 2030, Driven by Rising Veganism, Preventive Healthcare Focus, and Growth in Nutraceuticals: MarkNtel Advisors
Vitamin B12, scientifically known as cobalamin, is a water-soluble vitamin essential for red blood cell formation, neurological function, and DNA synthesis. Naturally occurring in animal-derived foods such as meat, fish, eggs, poultry, and dairy, it is notably absent from plant-based diets — creating
More news about: MarkNtel Advisors
Aug 14, 2025, 03:52 ET HKBU develops Microfluidic Flow Cytomolecular Analyser to promote extensive application of precision medicine
by signal receivers. This allows the analysis of both the surface and interior of the cells, including various parameters related to cell morphology, DNA, RNA, and proteins. Conventional flow cytometers have only one single channel. Detecting six or more parameters simultaneously requires multiple
More news about: Hong Kong Baptist University
Aug 13, 2025, 10:32 ET Whole Genome Sequencing Market to Reach New Heights by 2030
Global DNA Sequencing: Research, Applied and Clinical Markets: This report presents an in-depth analysis of the DNA sequencing market, focusing on its status and future potential. It explores market drivers,
More news about: BCC Research LLC
Aug 13, 2025, 09:04 ET Purina Opens Applications for 10th Annual Pet Care Innovation Prize
a crucial time for Basepaws. We were navigating significant resource constraints while working to bring the world's first comprehensive at-home cat DNA test to market," said Anna Skaya, founder of Basepaws. "The Prize provided not just financial support, but credibility
More news about: Purina
Aug 13, 2025, 08:00 ET Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
EsoGuard® Esophageal DNA Tests in 2Q25.Recognized $1.2 million in EsoGuard revenue for 2Q25.MolDX‑participating Medicare Administrative
More news about: Lucid Diagnostics
Aug 13, 2025, 08:00 ET The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP Join Forces to Award $2.5 Million in Neurodegenerative Disease Research Grants from 2025 Tauopathy Challenge Workshop
$500,000): This research examines the potential interaction between two amyloid-forming proteins—transactive response DNA binding protein 43 kDa (TDP-43) and tau—in neurodegenerative diseases such as PSP and frontotemporal lobar degeneration (FTLD). While both proteins are
More news about: The Rainwater Charitable Foundation
Aug 13, 2025, 08:00 ET Die Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association und CurePSP vergeben gemeinsam 2,5 Millionen Dollar an Forschungsgeldern für neurodegenerative Krankheiten aus dem 2025 Tauopathy Challenge Workshop
(500.000 $): Diese Forschungsarbeit untersucht die potenzielle Interaktion zwischen zwei amyloidbildenden Proteinen - dem transaktiven Response-DNA-Bindungsprotein 43 kDa (TDP-43) und Tau - bei neurodegenerativen Erkrankungen wie PSP und frontotemporaler Lobärdegeneration (FTLD). Während beide Proteine
More news about: The Rainwater Charitable Foundation
Aug 12, 2025, 16:30 ET DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health
of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Larsucosterol, DURECT's lead drug candidate, binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated
More news about: DURECT Corporation
Aug 12, 2025, 16:05 ET INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
About INOVIO's DNA Medicines PlatformINOVIO's DNA medicines platform has two innovative components: precisely designed DNA plasmids, delivered by INOVIO's proprietary investigational medical device, CELLECTRA. INOVIO uses proprietary technology to design its DNA plasmids, which are
More news about: INOVIO Pharmaceuticals, Inc.
Aug 12, 2025, 16:02 ET GRAIL Reports Second Quarter 2025 Financial Results
Galleri®The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique "fingerprint" of cancer, to help screen for some of the deadliest cancers that don't have recommended
More news about: GRAIL, Inc.
Aug 12, 2025, 11:05 ET Pew Awards 22 Researchers Biomedical Science Grants
Ph.D.Yale School of MedicineDr. Reilly will design programmable, synthetic cis-regulatory elements—DNA sequences that control gene expression—to facilitate the delivery and activation of therapeutic cargos to specific target tissues. Berna
More news about: The Pew Charitable Trusts
Aug 12, 2025, 11:00 ET Mice Model Market worth US$2.74 billion in 2030 with 10.0% CAGR | MarketsandMarkets™
attributed to its efficient and precise genome editing application. CRISPR/Cas9 systems use short guide RNAs and the Cas9 endonuclease to induce targeted DNA cleavage, enabling gene knockouts, base editing, and transgenesis. This method allows direct gene editing at the single-cell embryo stage, bypassing
More news about: MarketsandMarkets
Aug 12, 2025, 10:51 ET Rodrigo Zaborowsky assume como novo COO da Zabo Engenharia
que a Zabo tem de mais valioso – a excelência nos detalhes – e, ao mesmo tempo, projetar a empresa para os próximos 40 anos. Nosso objetivo é manter o DNA artesanal da marca, adaptando os produtos às novas demandas do mercado imobiliário", afirma Rodrigo. Além de liderar a operação no Brasil, o executivo
More news about: Zabo Engenharia
Aug 12, 2025, 10:00 ET Contify Launches Business News API v4, Empowering Product and Data Teams with Analysis-Ready Datasets, Featuring Key Highlights, Multilingual Translations, and New Advanced Endpoints
intelligence from the chaos of the web. We started by powering information aggregators with high-quality data feeds, and today, we're taking that same DNA forward," said Mohit Bhakuni, CEO of Contify. Key features of Business News API v4: AI-Generated
More news about: Contify
Aug 12, 2025, 09:54 ET Kyfora Bio Launches KyFect™ - AAV a next-generation transfection reagent. Engineered for discovery. Built for scale.
Leveraging the long history of Kyfora by Polysciences in specialty chemical manufacturing, KyFect™ - AAV is designed to synergistically enhance plasmid DNA binding and release at the appropriate stages of the transfection process. Built for flexibility and scale, it enables efficient plasmid delivery, high-yield
More news about: Kyfora Bio
Aug 12, 2025, 09:01 ET Ancestry Partners with the WWII Veterans History Project to Preserve the Stories of 80 WWII Veterans and Help Uncover Countless Others
family stories. With our unparalleled collection of more than 65 billion records, over 3 million subscribers and over 27 million people in our growing DNA network, customers can discover their family story and gain a new level of understanding about their lives. Over the past 40 years, we've built trusted
More news about: Ancestry
Aug 12, 2025, 09:00 ET Woven Solutions Announces Strategic Investment from Falfurrias Management Partners
acquisition opportunities to better support their mission partners' needs. Crucially, the partnership is designed to preserve the cultural and technical DNA that has made Woven successful, while equipping its leadership team to reach new levels of mission impact and scale. Equity for this investment
More news about: Woven Solutions
Aug 12, 2025, 08:01 ET Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
BOSTON, Aug. 12, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the appointment of Brian O'Sullivan as Head of Commercial
More news about: Ginkgo Bioworks
Aug 12, 2025, 08:00 ET Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology
further complementing Bayer's robust early precision oncology pipeline." Oncogenic driver mutations, such as KRAS mutations, are changes in the DNA of genes that drive the development and growth of cancer. These mutations are often identified as key targets for cancer treatment, and their identification
More news about: Kumquat Biosciences Inc.